Disaboom (OTCMKTS:MEDH – Get Free Report) and Nuwellis (NASDAQ:NUWE – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.
Profitability
This table compares Disaboom and Nuwellis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Disaboom | 15.34% | N/A | N/A |
| Nuwellis | -211.86% | -6,094.26% | -231.24% |
Institutional & Insider Ownership
3.1% of Nuwellis shares are held by institutional investors. 1.6% of Nuwellis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Disaboom | $1.76 million | 0.55 | $270,000.00 | $0.01 | 0.14 |
| Nuwellis | $8.27 million | 0.32 | -$17.52 million | ($90.92) | -0.01 |
Disaboom has higher earnings, but lower revenue than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than Disaboom, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Disaboom has a beta of 1.9, meaning that its stock price is 90% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for Disaboom and Nuwellis, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Disaboom | 0 | 0 | 0 | 0 | 0.00 |
| Nuwellis | 1 | 0 | 1 | 0 | 2.00 |
Summary
Disaboom beats Nuwellis on 8 of the 13 factors compared between the two stocks.
About Disaboom
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
About Nuwellis
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Receive News & Ratings for Disaboom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Disaboom and related companies with MarketBeat.com's FREE daily email newsletter.
